
Rex L Chisholm
Vice Dean for Scientific Affairs and Graduate Education
Adam and Richard T. Lind Professor of Medical Genetics
Professor, Cell and Developmental Biology, Surgery
Institutes & Centers
- Center for Diabetes and Metabolism
- Center for Genetic Medicine
- Institute for Augmented Intelligence in Medicine
- Institute for Public Health and Medicine (IPHAM)
- Northwestern University Clinical and Translational Sciences Institute (NUCATS)
- Northwestern University Institute of Neuroscience (NUIN)
- Robert H. Lurie Comprehensive Cancer Center
- Robert J. Havey, MD Institute for Global Health (IGH)
- Simpson Querrey Center for Neurogenetics
Most Recent Publications
- Nature. 2025 Apr; 640(8057): 146-154.PMID: 40011791
- A genomic mutational constraint map using variation in 76,156 human genomes( vol 625 , pg 92 , 2024)NATURE. 2024 Jan;ISSN: 0028-0836
- Nature. 2024 Jan; 625(7993): 92-100.PMID: 38057664
- Genetics. 2023 May; 224(1):PMID: 36866529
More Publications
Rex L Chisholm leads the following active clinical trials that are recruiting research participants/patients. Find all Feinberg Clinical Trials.
NUGene: Gene-Disease Associations and Treatment Outcomes
Rex L Chisholm, PhD reported no external professional relationships for calendar year 2023.
External Professional Relationships
Pharmaceutical, device, and biotechnology companies frequently collaborate with basic scientists and physicians within an academic medical center to help advance science and improve patient care. These relationships are important in achieving scientific breakthroughs and in establishing the effectiveness and safety of promising new therapies. In order to assure objectivity in clinical research and patient care, the Northwestern University Feinberg School of Medicine (Feinberg), Northwestern Memorial HealthCare, Children's Hospital of Chicago Medical Center, and the Shirley Ryan AbilityLab have adopted integrity policies that require research and clinical faculty (in full-time, part-time, and unpaid/voluntary categories) to report compensated and uncompensated external industry relationships. Patients are encouraged to discuss these disclosures with their physician as well as to inquire as to how these relationships are overseen by Feinberg. To learn more about our Disclosure and Professional Integrity Policy, and the conflict of interest policies of our joint affiliate survey partners, please go to our Office for Regulatory Affairs Policies page.
Feinberg will provide yearly disclosure updates to each faculty member’s profile. Please note there may be some discrepancies between this and other public sites as a result of different reporting periods or categorization of relationships. In addition, conference management, educational, and similar organizations may provide compensation to physicians on behalf of pharmaceutical, device, and biotechnology companies. If patients would like additional information regarding their physician’s relationships with these organizations, they should contact their physician directly.
Please click this link to submit Disclosure Feedback.